Introduction

This page provides a comprehensive analysis of the known insider trading history of Barry W Weiner. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Barry W Weiner has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ENZ / Enzo Biochem, Inc. PRESIDENT AND TREASURER 1,657,499
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Barry W Weiner. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Barry W Weiner as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-01-13 2021-01-11 4 ENZ ENZO BIOCHEM INC
Common Stock, par value $0.01 per share
A - Award 142,586 1,657,499 9.41
2020-02-27 2020-02-24 4/A ENZ ENZO BIOCHEM INC
Stock Option (to acquire Common Stock)
A - Award 116,900 268,389 77.17
2020-02-26 2020-02-24 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire Common Stock)
A - Award 116,900 268,389 77.17
2019-01-18 2019-01-14 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire common stock)
M - Exercise -33,305 151,489 -18.02
2019-01-18 2019-01-14 4 ENZ ENZO BIOCHEM INC
Common Stock
M - Exercise 2,226 1,136,918 0.20 2.70 6,010 3,069,679
2019-01-04 2019-01-03 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire common stock)
A - Award 115,000 184,794 164.77
2018-08-02 2018-07-31 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire common stock)
A - Award 80,000 152,294 110.66
2018-01-19 2018-01-17 4 ENZ ENZO BIOCHEM INC
Stock Option (to aquire common stock)
M - Exercise -30,802 184,794 -14.29
2018-01-19 2018-01-17 4 ENZ ENZO BIOCHEM INC
Common Stock
F - Taxes -11,626 1,290,485 -0.89 7.75 -90,102 10,001,259
2018-01-19 2018-01-17 4 ENZ ENZO BIOCHEM INC
Common Stock
S - Sale -11,000 1,302,111 -0.84 7.75 -85,250 10,091,360
2018-01-19 2018-01-17 4 ENZ ENZO BIOCHEM INC
Common Stock
M - Exercise 30,802 1,313,111 2.40 2.88 88,710 3,781,760
2017-10-27 2017-10-25 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire common stock)
M - Exercise -112,500 215,596 -34.29 3.00 -337,500 646,788
2017-10-27 2017-10-25 4 ENZ ENZO BIOCHEM INC
Common Stock
F - Taxes -33,449 1,335,792 -2.44 10.11 -338,169 13,504,857
2017-10-27 2017-10-25 4 ENZ ENZO BIOCHEM INC
Common Stock
S - Sale -54,126 1,369,241 -3.80 10.11 -547,214 13,843,027
2017-10-27 2017-10-25 4 ENZ ENZO BIOCHEM INC
Common Stock
M - Exercise 112,500 1,423,367 8.58 3.00 337,500 4,270,101
2017-01-10 2017-01-05 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire common stock)
A - Award 65,000 328,096 24.71
2016-03-16 2016-03-14 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire common stock)
A - Award 50,000 119,794 71.64
2015-01-23 2015-01-21 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire common stock)
A - Award 36,489 69,794 109.56
2014-01-22 2014-01-17 4 ENZ ENZO BIOCHEM INC
Stock option (to acquire common stock)
A - Award 33,305 33,305
2013-12-02 2013-11-26 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire Common Stock)
A - Award 112,500 112,500
2013-01-22 2013-01-17 4 ENZ ENZO BIOCHEM INC
Stock Option (to acquire Common Stock)
A - Award 30,802 30,802
2012-01-30 2012-01-26 4 ENZ ENZO BIOCHEM INC
Restricted Stock Units
A - Award 12,952 39,261 49.23
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)